Allan Meldgaard Lund

机构：University of Copenhagen, Copenhagen University Hospital, Rigshospitalet · ORCID：0000-0002-6091-7879

发表论文 290 篇 · 总被引 7815 次 · h-index 46

代表论文

• Effects of oral sepiapterin on blood Phe concentration in a broad range of patients with phenylketonuria (APHENITY): results of an international, phase 3, randomised, double-blind, placebo-controlled trial (2024 · The Lancet · 被引 43)
• Long‐term safety and efficacy of velmanase alfa treatment in children under 6 years of age with alpha‐mannosidosis: A phase 2, open label, multicenter study (2023 · Journal of Inherited Metabolic Disease · 被引 24)
• Newborn screening for adrenoleukodystrophy: International experiences and challenges (2023 · Molecular Genetics and Metabolism · 被引 22)
• Patients with primary carnitine deficiency treated with L‐carnitine are alive and doing well—A 10‐year follow‐up in the Faroe Islands (2023 · JIMD Reports · 被引 19)
• Extended long‐term efficacy and safety of velmanase alfa treatment up to 12 years in patients with alpha‐mannosidosis (2024 · Journal of Inherited Metabolic Disease · 被引 14)
• Severity-adjusted evaluation of liver transplantation on health outcomes in urea cycle disorders (2023 · Genetics in Medicine · 被引 13)